Trials / Completed
CompletedNCT02603406
Neovascularization Induced by Mechanical Barrier disrUption and Systemic Erythropoietin in Patients With Cerebral Perfusion Deficits
Neovascularization Induced by Mechanical Barrier disrUption and Systemic Erythropoietin in Patients With Cerebral Perfusion Deficits (NIMBUS Trial)
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 44 (actual)
- Sponsor
- Ajou University School of Medicine · Academic / Other
- Sex
- All
- Age
- 19 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
Neovascularization Induced by Mechanical Barrier disrUption and Systemic erythropoietin in patients with cerebral perfusion deficits (NIMBUS trial)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | erythropoietin |
Timeline
- Start date
- 2016-07-15
- Primary completion
- 2019-07-16
- Completion
- 2019-12-31
- First posted
- 2015-11-11
- Last updated
- 2020-08-19
Source: ClinicalTrials.gov record NCT02603406. Inclusion in this directory is not an endorsement.